Dr. Utpal Nandi

Employment

• Bose Institute Associate Professor
  2024 - Present
• CSIR-Indian Institute of Integrative Medicine Senior Scientist
  2019 - 2024
• CSIR-Indian Institute of Integrative Medicine Scientist
  2015 - 2019
• Indian Pharmacopoeia Commission (IPC) Scientific Assistant
  2012 - 2015

Education

• Jadavpur University Ph.D. in Pharmacy
  2009 - 2013
• Jadavpur University Master of Pharmacy
  2007 - 2009
• Jadavpur University Bachelor of Pharmacy
  2003 - 2007

Projects & Funding

Projects & funding information is unavailable.

Publications (106)

• Self-emulsifying formulation of andrographolide: Development, characterization and investigation on pharmacokinetics and pharmacological profile
  Journal of Drug Delivery Science and Technology 2025 DOI: 10.1016/j.jddst.2025.107290
  +Save
• The interplay between genotoxic stress and STING activation in cellular senescence and inflammatory responses
  International Immunopharmacology 2025 DOI: 10.1016/j.intimp.2025.115371
  +Save
• Isobavachalcone ameliorates Alzheimer disease pathology by autophagy-mediated clearance of amyloid beta and inhibition of NLRP3 inflammasome in primary astrocytes and 5x-FAD mice
  Frontiers in Pharmacology 2025 DOI: 10.3389/fphar.2025.1525364
  +Save
• Evaluation of Pyrrolone‐Fused Benzosuberene MK2 Inhibitors as Promising Therapeutic Agents for HNSCC: In Vitro Efficacy, In‐Vivo Safety, and Pharmacokinetic Profiling
  Drug Development Research 2025 DOI: 10.1002/ddr.70062
  +Save
• Discovery and biological evaluation of nitrofuranyl–pyrazolopyrimidine hybrid conjugates as potent antimicrobial agents targeting Staphylococcus aureus and methicillin-resistant S. aureus
  RSC Medicinal Chemistry 2025 DOI: 10.1039/d4md00826j
  +Save
• Silicon incorporated tacrine: design, synthesis, and evaluation of biological and pharmacokinetic parameters
  RSC Medicinal Chemistry 2025 DOI: 10.1039/d5md00019j
  +Save
• Discovery of Ring-Annulated Analogues of Cannabidiol as Potential Anticancer Agents: Synthesis and Biological Evaluation
  ACS Medicinal Chemistry Letters 2024 DOI: 10.1021/acsmedchemlett.4c00233
  +Save
• Identification of a novel GSK3β inhibitor involved in abrogating KRas dependent pancreatic tumors in Wnt/beta-catenin and NF-kB dependent manner
  Life Sciences 2024 DOI: 10.1016/j.lfs.2024.122840
  +Save
• A path from synthesis to emergency use authorization of molnupiravir as a COVID-19 therapy
  Bioorganic Chemistry 2024 DOI: 10.1016/j.bioorg.2024.107379
  +Save
• ADME/PK Insights of Crocetin: A Molecule Having an Unusual Chemical Structure with Druglike Features
  ACS Omega 2024 DOI: 10.1021/acsomega.4c02116
  +Save